- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Quadrature Capital Ltd Acquires $19.6M Stake in Johnson & Johnson
The institutional investor added over 105,000 shares of the healthcare giant to its portfolio in Q3.
Mar. 13, 2026 at 10:52am
Got story updates? Submit your updates here. ›
Quadrature Capital Ltd, an institutional investor, acquired a new stake in Johnson & Johnson (NYSE:JNJ) during the third quarter, according to a recent SEC filing. The firm purchased 105,744 shares of the company's stock, valued at approximately $19.6 million.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a portfolio spanning pharmaceuticals, medical devices, and consumer products. This investment by Quadrature Capital suggests the firm sees long-term growth potential in JNJ's business.
The details
Quadrature Capital's new position in Johnson & Johnson was disclosed in a 13F filing with the SEC. The filing shows the firm added over 105,000 shares of JNJ stock to its portfolio during the third quarter of 2026. This stake is valued at approximately $19.6 million based on JNJ's share price at the time.
- Quadrature Capital acquired the new stake in Johnson & Johnson during the third quarter of 2026.
The players
Quadrature Capital Ltd
An institutional investor that acquired a new $19.6 million stake in Johnson & Johnson in Q3 2026.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer products.
The takeaway
Quadrature Capital's investment in Johnson & Johnson reflects the firm's confidence in the healthcare giant's long-term growth prospects. As one of the world's leading diversified healthcare companies, JNJ continues to attract interest from major institutional investors.
